Zobrazeno 1 - 5
of 5
pro vyhledávání: '"James Butera"'
Autor:
Diana O. Treaba, Dennis M. Bonal, Anna Chorzalska, Mireia Castillo‐Martin, Alissa Oakes, Makayla Pardo, Max Petersen, Christoph Schorl, Kelsey Hopkins, Dean Melcher, Ting C. Zhao, Olin Liang, Eui‐Young So, John Reagan, Adam J. Olszewski, James Butera, Douglas C. Anthony, Peter Rintels, Peter Quesenberry, Patrycja M. Dubielecka
Publikováno v:
British journal of haematologyREFERENCES.
While the bone marrow (BM) microenvironment is significantly remodelled in acute myeloid leukaemia (AML), molecular insight into AML-specific alterations in the microenvironment has been historically limited by the analysis of liquid marrow aspirates
Autor:
Thomas Ollila, James Butera, Pamela Egan, John Reagan, Anthony Thomas, Inna Yakirevich, Kelsey MacKinnon, Jeannine Margolis, Jessica McMahon, Valerie Rosati, Adam J Olszewski
Publikováno v:
The oncologist. 27(7)
Background We conducted an investigator-initiated, phase I trial of vincristine sulfate liposomal injection (VSLI) in combination with bendamustine and rituximab (BR) for indolent B-cell (BCL) or mantle cell lymphoma. Methods Participants received 6
Autor:
Adam J. Olszewski, Anna Chorzalska, Diana O. Treaba, John L. Reagan, Andrew Hsu, Pamela C. Egan, Habibe Kurt, James Butera, William Rafelson, Thomas Ollila, Rabin Niroula, Jordan Robison, Chelsea D. Mullins, Patrycja M. Dubielecka
Publikováno v:
Cancer Research. 80:733-733
Current methods for detection of CNS involvement in lymphoma (CSF cytology, flow cytometry) have very limited sensitivity, particularly in cases of parenchymal brain involvement. Early detection is however critical to institute CNS-directed therapy t
Autor:
Rabin, Niroula, James, Butera
Publikováno v:
Rhode Island medical journal (2013). 98(11)
Diffuse large B-Cell lymphoma (DLBCL) is one of the most common and aggressive subtypes of non-Hodgkin's lymphoma (NHL). Gene expression profiling (GEP) studies have identified at least two distinct molecular subtypes of DLBCL termed as germinal cent
Autor:
James Butera, John Maynard, Frank Cummings, Wallace Akerley, Barry Stein, Terek Wehbe, Louis Leone, Richard Noto, Gregory Di Rienzo, Howard Safran, Sundaresan Sambandam
Publikováno v:
Cancer. 94(6)
BACKGROUND Estramustine phosphate (EMP) and vinblastine have radiosensitizing properties and significant activity against hormone refractory prostate carcinoma. Strontium-89 is a palliative agent that acts as a selective radiation source for bone met